Modern management of vulvar cancer

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 1, 2004, Pages 65-72

  De Hullu, Joanne A ^a   Oonk, Maaike H M ^b   Van Der Zee, Ate G J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Lymph node metastases; Morbidity; Radiotherapy; Recurrences; Sentinel lymph node; Vulvar cancer

Indexed keywords

TRACER;

CANCER CONTROL; CANCER CYTODIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EARLY CANCER; ECHOGRAPHY; EXCISION; HISTOPATHOLOGY; HUMAN; INCISION; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; MINIMALLY INVASIVE SURGERY; MORBIDITY; NEEDLE BIOPSY; NON INVASIVE MEASUREMENT; PATIENT CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SAFETY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR BIOPSY; VULVA CANCER; VULVA CARCINOMA; VULVECTOMY;

FEMALE; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; RADIOTHERAPY; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 1242339710     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200402000-00012     Document Type: Review

References (73)

1. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology, 3rd ed. Baltimore: Williams and Wilkins; 2000. pp. 553-596.
2. Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983; 62:457-462.
3. Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983; 61:63-74.
4. Burke TW, Levenback C, Coleman RL, et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995; 57:215-220.
5. 0) disease. Gynecol Oncol 1994; 53:55-58.
6. Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38:309-314.
7. de Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma: the price of less radical surgery. Cancer 2002; 95:2331-2338. This study confirms the importance of tumour-free margins in the wide local excision. The advice is to perform the local excision with margins of 2 cm. Moreover, the study warns that attention should be paid to the higher regional recurrence rate since the introduction of separate incisions.
8. Sedlis A, Homesley H, Bundy BN, et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. Am J Obstet Gynecol 1987; 156:1159-1164.
9. Hicks ML, Hempling RE, Piver MS. Vulvar carcinoma with 0.5 mm of invasion and associated inguinal lymph node metastasis. J Surg Oncol 1993; 54:271-273.
10. Atamtede F, Hoogerland D. Regional lymph node recurrence following local excision for microinvasive vulvar carcinoma. Gynecol Oncol 1989; 34:125-128.
11. Van der Velden J, Kooyman CD, Van Lindert ACM, Heintz APM. A stage IA vulvar carcinoma with an inguinal lymph node recurrence after local excision: a case report and literature review. Int J Gynecol Cancer 1992; 2:157-159.
12. Magrina JF, Gonzalez-Bosquet J, Weaver AL, et al. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol 2000; 76:24-27.
13. Homesley HD, Bundy B, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a GOG Study). Gynecol Oncol 1993; 49:279-283.
14. Rutledge FN, Mitchell MF, Munsell MF, et al. Prognostic indicators for invasive carcinoma of the vulva. Gynecol Oncol 1991; 42:239-244.
15. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983; 16:179-189.
16. Burger MPM, Hoilema H, Bouma J. The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 1996; 6:318-322.
17. Jackson KS, Das N, Naik R, Lopes A, Monaghan JM. Contralateral groin node metastastasis following ipsilateral groin node dissection in vulval cancer: a case report. Gynecol Oncol 2003; 89:529-531.
18. Gordinier ME, Malpica A, Burke TW, et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 2003; 90:625-628. An overview of an impressive high groin recurrence rate in the Texas M.D. Anderson Cancer Centre. The groin recurrence rate after lymphadenectomy with negative lymph nodes in this study was much higher than in earlier reports.
19. Stehman FB, Bundy BN, Dvoretsky PM, et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992; 79:490-497.
20. Levenback C, Morris M, Burke TW, et al. Groin dissection practices among gynaecologic oncologists treating early vulvar cancer. Gynecol Oncol 1996; 62:73-77.
21. Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981; 58:574-579.
22. Schulz MJ, Penalver M. Recurrent vulvar carcinoma in the intervening tissue bridge in early invasive stage I disease treated by radical vulvectomy and bilateral groin dissection through separate incisions. Gynecol Oncol 1989; 35:383-386.
23. Grimshaw RN, Murdoch JB, Monaghan JM. Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions: experience with 100 cases. Int J Gynecol Cancer 1993; 3:18-23.
24. Christopherson W, Buchsbaum HJ, Voet R, Lifschitz S. Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 1985; 21:247-251.
25. Rose PG. Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer 1999; 9:508-511.
26. Hopkins MP, Reid GC, Morley GW. Radical vulvectomy: the decision for the incision. Cancer 1993; 72:799-803.
27. Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva (Cochrane Review). In: Cochrane Library, Issue 1. Oxford: Update Software; 2002. A very good review with a critical selection of publications.
28. Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995; 57:327-334.
29. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68:733-740.
30. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a GOG study). Am J Obstet Gynecol 1991; 164:997-1004.
31. Lin JY, DeBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992; 47:80-86.
32. Gould N, Kamelle S, Tillmanns T, et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 2001; 82:329-332.
33. Zhang SH, Sood AK, Sorosky JI, et al. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 2000; 89:1520-1525.
34. Rouzier R, Haddad B, Dubernard G, et al. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003; 196:442-450. A recent clinical study on the morbidity of surgery in vulvar cancer patients.
35. Gonzalez Bosquet JG, Kinney WK, Russell AH, et al. Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003; 57:419-424. A retrospective analysis was carred out to investigate the risk of subclinical metastasis, which may be helpful in making the decision regarding treatment of the groin.
36. 11C)-tyrosine positron emission tomography. Int J Gynecol Cancer 1999; 9:141-146.
37. Sohaib SA, Richards PS, Ind T, et al. MR imaging of carcinoma of the vulva. Am J Roentgenol 2002; 178:373-377. The preliminary results of the possible role of magnetic resonance imaging in the detection of inguinofemoral lymph node metastases.
38. Hawnaur JM, Reynolds K, Wilson G, et al. Identification of inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: in initial report. Clin Radiol 2002; 57:995-1000. The preliminary results of the possible role of magnetic resonance imaging in the detection of inguinofemoral lymph node metastases.
39. Abang Mohammed DK, Uberoi R, de B Lopes A, Monaghan JM. Inguinal node status by ultrasound in vulvar cancer. Gynecol Oncol 2000; 77:93-96.
40. Hall TB, Barton DPJ, Trott PA, et al. The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol 2003; 58:367-371. The largest series of ultrasound-guided cytology in vulvar cancer patients. The reliable exclusion of lymph node metastases will never be possible. There might be a role for the preoperative detection of lymph node metastases, leading to direct complete inguinofemoral lymphadenectomy instead of the sentinel lymph node procedure.
41. Ahuja A, Ying M, Yang WWT, et al. The use of sonography in differentiating cervical lymphomatous lymph nodes from cervical metastastic lymph nodes. Clin Radiol 1996; 51:186-190.
42. Mäkelä PJ, Leminen A, Kääriäinen M, Lehtovirta P. Pretreatment sonographic evaluation of inguinal lymph nodes in patients with vulvar malignancy. J Ultrasound Med 1993; 5:255-258.
43. DiSaia PJ, Creasman WT, Rich WM. An alternative approach to early cancer of the vulva. Am J Obstet Gynecol 1979; 133:825-830.
44. Levenback C, Burke TW, Gershenson DM, et al. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994; 84:163-167.
45. Levenback C, Coleman RL, Burke TW, et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001; 83:276-281.
46. Levenback C, Burke TW, Morris M, et al. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59:216-220.
47. deCesare SL, Fiorica JV, Roberts WS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997; 66:425-428.
48. de Hullu JA, Doting MHE, Piers DA, et al. Sentinel lymph node identification with Technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998; 39:1381-1385.
49. DeCicco C, Sideri M, Bartolomei M, et al. Sentinel node detection by lymphoscintigraphy and gamma detecting probe in patients with vulvar cancer. J Nucl Med 1997; 38:33P.
50. Tavares MGM, Sapienza MT, Galeb NA, et al. The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med 2001; 28:1597-1604.
51. Molpus KL, Kelley MC, Johnson JE, et al. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med 2001; 46:863-869.
52. Makar APH, Scheistroen M, van den Weyngaert D, Tropé CG. Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer 2001; 11:255-262.
53. Sliutz G, Reinthaller A, Lantzsch T, et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 2002; 84:449-452.
54. Echt ML, Finan MA, Hoffman MS, et al. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999; 92:204-208.
55. Ansink AC, Sie-Go DMDS, van der Velden J, et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection. Cancer 1999; 86:652-656.
56. DeCicco C, Sideri M, Grana C, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000; 82:295-299.
57. de Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000; 18:2811-2816.
58. Moore RG, Depasquale SE, Steinhoff MM, et al. Sentinel node identification and the ability to detect metastastic tumor to inguinal lymph nodes in vulvar malignancies. Gynecol Oncol 2003; 89:475-479.
59. Puig-Tintoré LM, Ordi J, Vidal-Sicart S, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 2003; 88:29-34.
60. Van Diest PJ, Torrenga H, Hollema H, et al. Ultra-staging of the sentinel node. In: Levenback C, Coleman RL and van der Zee AGJ. Clinical lymphatic mapping in gynecologic oncology; Martin Dunitz, 2003. Very good overview of all different histopathological techniques to examine a sentinel lympyh node.
61. Scholz HS, Lax SF, Benedicic C, et al. Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB1 to IIB cervical cancer. Gynecol Oncol 2003; 90:605-609. The accuracy of frozen section in cervical cancer appeared to be 80%.
62. Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000; 76:40-44.
63. Stehman F, Bundy B, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys 1992; 24:389-396.
64. Koh WJ, Chiu M, Stelzer KJ, et al. Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys 1993; 15:969-974.
65. Petereit DG, Mehta MP, Buchler DA, Kinsella TJ. Inguinofemoral radiation of N0, N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 1993; 27:963-967.
66. Van der Velden J, Ansink A. Primary groin irradiation versus primary groin surgery for early vulvar cancer (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software; 2002. A good review with a strict selection of literature.
67. Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003; 57:409-418. An overview of treatment of the groin in vulvar cancer patients with a very high overall groin recurrence rate. Primary radiotherapy with the optimal technique is suggested as an appropriate treatment for many vulvar cancer patients to prevent groin recurrences and morbidity.
68. Dunton CJ, Kautzky M, Hanau C. Malignant melanoma of the vulva; a review. Obstet Gynecol Surv 1995; 50:739-746.
69. Raber G, Mempel V, Jackisch C, et al. Malignant melanoma of the vulva: report of 89 patients. Cancer 1996; 78:2353-2358.
70. Ragnarsson-Olding N, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina: trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993; 71:1893-1897.
71. Ragnarsson-Olding BK, Kanter-Lewenhsohn LR, Lagerlöf B, et al. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer 1999; 86:1273-1284.
72. De Hullu JA, Hollema H, Hoekstra HJ, et al. Vulvar melanoma: is there a role for sentinel lymph node biopsy? Cancer 2002; 94:486-491. The first series of nine patients with vulvar melanoma who underwent the sentinel lymph node procedure as 'standard care'. Two groin recurrences after negative sentinel lymph node were identified, probably in-transit metastases. The pros and cons of this technique in patients with vulvar melanoma are discussed.
73. Gershenwald JE, Mansfield PF, Lee JE, et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma. Ann Surg Oncol 2000; 7:160-165.